Polydimethylsiloxane, trimethylsiloxy terminated 500cSt, 100g

6-hydrazinoimidazo[1,2-b]pyridazine, 95.0%, 5g

5-Fluoro-4-iodo-2-methylaniline, 97%, 1g

N-Succinimidyl S-Acetylthioglycolate [Cross-linking Reagent]>94.0%(GC)5g

Methyl 2-(bromomethyl)-5-iodobenzoate, 95.0%, 5g

2-Bromo-5,6-dihydro-4H-pyrazolo[1,5-d][1,4]diazepin-7(8H)-one, 98%, 100mg

5-(Bromoacetyl)-3-(4-chlorophenyl)isoxazole, 95.0%, 250mg

trans-2,5-Diethylpiperazine, 98%, 1g

Cyclopentane-1,3-dicarboxylic acid, 95.0%, 10g

2-Bromo-2',4'-difluoroacetophenone, 97.0%, 5g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-((tert-butyldimethylsilyl)oxy)propanoic acid, 95+%, 250mg

N-(2,4-Dimethylphenyl)-3-hydroxy-2-naphthamide, 98%, 5g

tert-Butyl 4-(4-bromophenyl)piperazine-1-carboxylate, 95.0%, 1g